LXEO
Lexeo Therapeutics, Inc.
3.40$
-3.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | |
| – | 0.8% | 175.1% | – | – | – | |
| 100.0% | 100.0% | 100.0% | – | – | – | |
| 833.0% | 2,723.1% | 7,517.1% | – | – | – | |
| 151.9% | 432.9% | 1,835.0% | – | – | – | |
| 984.9% | 3,155.9% | 9,352.1% | – | – | – | |
| -884.9% | -3,055.9% | -9,252.1% | – | – | – | |
| 28.4% | 0.0% | 13.9% | – | – | – | |
| -993.8% | -3,055.0% | -9,063.8% | – | – | – | |
| 28.4% | 0.0% | 13.6% | – | – | – | |
| -993.8% | -3,055.0% | -9,063.8% | – | – | – | |
| -884.9% | -3,054.3% | -8,874.8% | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.